These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 13510731)

  • 21. Serum transaminase; clinical experience with 211 patients.
    BUNCH LD; ARCHER WH; NORRIS GL
    J Kans Med Soc; 1957 Aug; 58(8):513-23. PubMed ID: 13449390
    [No Abstract]   [Full Text] [Related]  

  • 22. [Value of the determination of serum glutamic-oxalacetic transaminase and serum glutamic-pyruvic transaminase in the diagnosis of myocardial infarct and liver disease].
    BOSTANCI N; BIYAL F
    Turk Tip Cemiy Mecm; 1959 Sep; 25():444-54. PubMed ID: 13803091
    [No Abstract]   [Full Text] [Related]  

  • 23. [Blood transaminases].
    SCHILL B
    Maroc Med; 1959 May; 38(408):733-6. PubMed ID: 13673668
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibrinolytic activator, glutamic oxaloacetic transaminase and potassium in myocardial tissue at various stages of human myocardial infarction.
    FISCHER S; ALBRECHTSEN OK; BANG NU
    Thromb Diath Haemorrh; 1959 Sep; 3():554-65. PubMed ID: 13823131
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute hepatic necrosis following iproniazid therapy; value of glutamic-oxaloacetic transaminase estimation in early detection.
    PARE CM; SANDLER M
    Lancet; 1959 Feb; 1(7067):282-4. PubMed ID: 13631997
    [No Abstract]   [Full Text] [Related]  

  • 26. [Critical analysis of the blood glutamic oxalacetic and glutamic pyruvic transaminases in hepatology (Apropos of 100 paired determinations accomplished during the observation of 50 patients)].
    MORETTI G; STAEFFEN J; BALLAN P; DEMANGE G
    J Med Bord; 1959 Sep; 136():1043-8. PubMed ID: 14424078
    [No Abstract]   [Full Text] [Related]  

  • 27. [The prognostic significance of high SGOT titer in myocardial infarct].
    MASSON NG; VERHEUGT AP
    Ned Tijdschr Geneeskd; 1962 Apr; 106():858-61. PubMed ID: 14470955
    [No Abstract]   [Full Text] [Related]  

  • 28. [Glutamic acid-pyruvic acid transaminase in liver diseases].
    FRANKEN FH
    Klin Wochenschr; 1957 Dec; 35(24):1203-6. PubMed ID: 13515168
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum glutamic oxalacetic-transaminase activity in the diagnosis of myocardial infarction and hepatic necrosis.
    WALTERS MN; LITTLEJOHN PG
    Med J Aust; 1958 Jan; 45(3):76-80. PubMed ID: 13503423
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serum glutamic-oxalacetic and glutamic-pyruvic transaminases in myocardial infarct].
    FORTIN P; PERROTIN M
    Prog Med (Paris); 1959 Sep; 87():300-4. PubMed ID: 13824065
    [No Abstract]   [Full Text] [Related]  

  • 31. Differences in the distribution of glutamic acid-oxalacetic acid transaminase- and aldolase-activity among serum protein fractions in patients with acute myocardial infarct and hepatocellular damage.
    TENYI M; VARGA L; KOVACS I; LEHOTAY L
    Med Exp Int J Exp Med; 1961; 4():335-40. PubMed ID: 13920250
    [No Abstract]   [Full Text] [Related]  

  • 32. Experience with serum glutamic oxaloacetic transaminase.
    BERKMAN F; BHARGAVA AN
    Can Med Assoc J; 1959 Jun; 80(11):861-5. PubMed ID: 13662936
    [No Abstract]   [Full Text] [Related]  

  • 33. [On increase of glutamic-oxalic transaminase (SGPT) activity in myocardial infarction].
    RAFALOWICZ A
    Pol Tyg Lek; 1961 Oct; 16():1529-31. PubMed ID: 14489823
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blood transaminases in liver diseases. Importance of the glutamic oxalacetic-glutamic pyruvic ratio].
    NERY AL; GRANATO PO
    Rev Bras Med; 1959 Jun; 16():399-401. PubMed ID: 14426559
    [No Abstract]   [Full Text] [Related]  

  • 35. [Glutamic-oxalacetic transaminase and myocardial infarct].
    MAURICE P
    Prog Med (Paris); 1961 Jan; 89():37-9. PubMed ID: 13768440
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum glutamic oxaloacetic transaminase elevation and possible hepatotoxicity accompanying the administration of ethionamide.
    PHILLIPS S; TREVATHAN RD
    Am Rev Respir Dis; 1962 Aug; 86():268-9. PubMed ID: 14486256
    [No Abstract]   [Full Text] [Related]  

  • 37. Glutamic-oxalacetic transaminase in the diagnosis of myocardial infarction. I. Serum transaminase activity in relation to the clinical picture.
    BIORCK G; HANSON A
    Acta Med Scand; 1956 Oct; 155(4):317-24. PubMed ID: 13361845
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum glutamic oxalacetic transaminase. Specificity of values in hepatocellular injury.
    WIRTSCHAFTER ZT; TSUJIMURA JK
    Arch Environ Health; 1961 Jan; 2():16-22. PubMed ID: 13785982
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum glutamic oxalacetic transaminase in acute myocardial infarction.
    DEWAR HA; ROWELL NR; SMITH AJ
    Br Med J; 1958 Nov; 2(5105):1121-5. PubMed ID: 13584872
    [No Abstract]   [Full Text] [Related]  

  • 40. [The elevation of the glutamic-oxalacetic transaminase level in the blood after myocardial infarction. Critical study and diagnostic value].
    WELTI JJ; NIVET M
    Presse Med (1893); 1960 Apr; 68():826-8. PubMed ID: 13843938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.